# Dysport® Adult Lower Limb Spasticity Follow-on Study

> **NCT01251367** · PHASE3 · COMPLETED · sponsor: **Ipsen** · enrollment: 352 (actual)

## Conditions studied

- Post-stroke Spasticity
- Spasticity Post-Traumatic Brain Injury

## Interventions

- **BIOLOGICAL:** Botulinum toxin type A

## Key facts

- **NCT ID:** NCT01251367
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 352 (ACTUAL)
- **Last updated:** 2022-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01251367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01251367, "Dysport® Adult Lower Limb Spasticity Follow-on Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01251367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*